Despite a 10% revenue dip from Medicaid-related Natroba declines, Cipher boosts Epuris market share to 47.1% and secures a major Walmart retail partnership.

Cipher Pharmaceuticals (TSE:CPH) reported lower second-quarter revenue and earnings as sales of its U.S. Natroba treatment declined, while its Canadian Epuris product posted growth and market-share gains. Management said the company remains focused on expanding commercial channels for Natroba, widen

Investors in Cipher Pharmaceuticals Inc. ( TSE:CPH ) had a good week, as its shares rose 9.8% to close at CA$19.74...

The Canadian market, much like its global counterparts, is navigating a complex landscape where uncertainty around energy supply disruptions and geopolitical tensions looms large. Despite these challenges, the potential for small- and mid-cap stocks to sustain relative momentum offers intriguing opportunities for investors seeking growth. In this environment, identifying undiscovered gems requires a keen eye for companies with strong fundamentals that can thrive amidst cyclical shifts and...

Stifel Canada has raised its price target on Cipher Pharmaceuticals (CPH.TO) by $1.00, to $21.00 and

Cipher Pharmaceuticals Inc (CPHRF) reports robust financial performance with significant revenue and earnings growth, driven by successful Natroba sales and strategic debt reduction.

Cipher Pharmaceuticals Inc (CPHRF) reports significant growth in revenue and net income, driven by Natroba sales and strategic debt reduction.

As we enter 2026, the Canadian market has demonstrated remarkable resilience amid a flurry of geopolitical tensions and U.S. policy shifts, with fundamentals like low energy prices and solid growth anchoring market stability. In this environment, identifying undiscovered gems requires a keen eye for stocks that not only withstand headline volatility but also capitalize on broadening market leadership and robust economic indicators.

As 2025 comes to a close, the Canadian market is navigating through a complex landscape marked by easing inflation pressures and stabilizing labor markets, setting an optimistic tone for 2026. In this environment, investors might find value in exploring small-cap stocks that demonstrate resilience and potential growth amid broader market rotations and improving economic conditions.